|
Cloning Kit new Mutagenesis Kit new Competent Cells new Signal Enhancer SmartBlot IP/Western Blot Monoclonal Antibody Human Virus new Secondary Antibody siRNA Chemokines
|
||
|
|
CXCL12a
(HB-68): va-1207
·
Synonyms:
PBSF, SCYB12, SDF-1a, SDF-1b, SDF1, SDF1A, SDF1B, TLSF-a, TLSF-b, TPAR1 ·
68
amino acid residues of CXCL12a of human
origin ·
Gene
bank accession number: NP_000600 ·
Biologically
active protein produced in E. coli ·
Greater
than 98% by SDS-PAGE ·
Determined
by its ability to chemoattract human peripheral T cells activated with PHA
and IL-2 using a concentation of 20-80 ng/ml.
|
|
CXCL12b
(MB-72): va-1208
·
Synonyms:
PBSF, PBSF/SDF-1, SDF-1, Scyb12, Sdf1, Sdf1a, Sdf1b, TLSF, TLSF-a, TLSF-b,
TPAR1 ·
72 amino
acid residues of CXCL12b of murine
origin ·
Gene bank
accession number: NP_038683 ·
Biologically
active protein produced in E. coli ·
Greater
than 98% by SDS-PAGE · Determined by its ability to chemoattract human peripheral blood monocytes using a concentration of 50-100 ng/ml.
|
|
CXCL12b
(HB-72): va-1209
·
Synonyms:
PBSF, SCYB12, SDF-1a, SDF-1b, SDF1, SDF1A, SDF1B, TLSF-a, TLSF-b, TPAR1 ·
72
amino acid residues of CXCL12b of human
origin ·
Gene
bank accession number: NP_000600 ·
Biologically
active protein produced in E. coli ·
Greater
than 98% by SDS-PAGE · Determined by its ability to chemoattract human peripheral T cells activated with PHA and IL-2 using a concentation of 20-80 ng/ml
|
|
CXCL13
(HB-85): va-1010
·
Synonyms:
BLC; BCA1; ANGIE; BCA-1; BLR1L; ANGIE2; SCYB13 ·
85
amino acid residues of CXCL13 of human origin ·
Gene
bank accession number: NP_006410 ·
Biologically
active protein produced in E. coli ·
Greater
than 98% by SDS-PAGE · Determined by its ability to chemoattract human B cells using a concentration range of 1.0-10.0 ng/ml.
|